Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Blood
|
December 8, 2022
Engineering builds multipotency for iPSC-NKs
Ruyan Rahnama, Challice L Bonifant
Cancer Biology & Therapy
|
August 27, 2005
'Cables' suspends cancer in mice
Challice L Bonifant, Todd Waldman
Current Opinion in Pediatrics
|
December 19, 2019
The future of cellular immunotherapy for childhood leukemia
Challice L Bonifant, Sarah K Tasian
Blood
|
August 28, 2025
Driving CAR-Ts SafeSLE
Challice L Bonifant, Nirali N Shah
Blood
|
December 25, 2025
Armed and SAVVY: CAR T cells combat AML
Megan T Zinsky, Challice L Bonifant
Hematology/Oncology Clinics of North America
|
June 30, 2022
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies
Ruyan Rahnama, Ilias Christodoulou, Challice L Bonifant
British Journal of Haematology
|
July 24, 2025
CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia
Alexandra Dreyzin, Noa G Holtzman, Challice L Bonifant
Expert Opinion on Biological Therapy
|
September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemia
Challice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Blood
|
November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodies
Mireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Journal of Cellular Biochemistry
|
September 6, 2007
NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN
Challice L Bonifant, Jung-Sik Kim, Todd Waldman
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Blood
|
December 8, 2022
Engineering builds multipotency for iPSC-NKs
Ruyan Rahnama, Challice L Bonifant
Cancer Biology & Therapy
|
August 27, 2005
'Cables' suspends cancer in mice
Challice L Bonifant, Todd Waldman
Current Opinion in Pediatrics
|
December 19, 2019
The future of cellular immunotherapy for childhood leukemia
Challice L Bonifant, Sarah K Tasian
Blood
|
August 28, 2025
Driving CAR-Ts SafeSLE
Challice L Bonifant, Nirali N Shah
Blood
|
December 25, 2025
Armed and SAVVY: CAR T cells combat AML
Megan T Zinsky, Challice L Bonifant
Hematology/Oncology Clinics of North America
|
June 30, 2022
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies
Ruyan Rahnama, Ilias Christodoulou, Challice L Bonifant
British Journal of Haematology
|
July 24, 2025
CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia
Alexandra Dreyzin, Noa G Holtzman, Challice L Bonifant
Expert Opinion on Biological Therapy
|
September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemia
Challice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Blood
|
November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodies
Mireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Journal of Cellular Biochemistry
|
September 6, 2007
NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN
Challice L Bonifant, Jung-Sik Kim, Todd Waldman
Page
of 5